Mentari Therapeutics, Inc. (MTRI)
Industry: Biotechnology
Mentari Therapeutics, Inc.
NASDAQ:MTRIHealthcare · Drug Manufacturers - Specialty & Generic
-11.93%$17.50
CLOSED · Nov 17Prev close$19.87-11.93%Close$17.500.00%AH close$17.50
AH$17.50+0.00%vs close
Mkt Cap$924.24M
EV-
Float35.49M
O/S52.81M
VOL171K sh
$ Vol$3.08M
RVOL5.22×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsFeb 10 · in 3mo
Dilution
MCap$924.24MFloat35.49MO/S52.81M
Dilution
Pipeline1 lead-sponsored trial·0 active1 completed
Trials need funding. See this company's dilution risk and cash position.
Clinical Trials
- Phase 2Completed
INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa
INM-755 (cannabinol) cream, Vehicle Cream
Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional +2
NCT04908215Enrollment19StartDec 2021Primary CompletionApr 2023CompletionApr 2023
| Drug / Therapy | Link | ||
|---|---|---|---|
| Phase 2 | Completed | INM-755 (cannabinol) cream, Vehicle Cream | NCT04908215 |